| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/28/2008 | US20080206862 High surface cultivation system bag |
| 08/28/2008 | US20080206860 Vessel and Culture System Including |
| 08/28/2008 | US20080206837 Stable adenoviral vectors and methods for propagation thereof |
| 08/28/2008 | US20080206834 Recombinant organophosphorous acid anhydrase and methods of use |
| 08/28/2008 | US20080206832 selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents |
| 08/28/2008 | US20080206822 Method for Improving the Thermostability of Sucrose Phosphorylase (Sp) |
| 08/28/2008 | US20080206819 growing cells in a perfusion system using induction agents without a substantial loss of cell viability; agent is sodium butyrate |
| 08/28/2008 | US20080206815 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same |
| 08/28/2008 | US20080206813 Means and methods for regulating gene expression |
| 08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 08/28/2008 | US20080206810 lacking all or a portion of the ST6GalNAcI signal domain; nucleic acids encoding such truncated polypeptides, as well as vectors, host cells, expression systems |
| 08/28/2008 | US20080206805 Compounds and Related Methods for Mutant p53 Reactivation |
| 08/28/2008 | US20080206788 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 08/28/2008 | US20080206786 Trace amine receptor 1 of the african green monkey |
| 08/28/2008 | US20080206750 Novel fetal genes |
| 08/28/2008 | US20080206744 Functional Genomics and Gene Trapping in Haploid or Hypodiploid Cells |
| 08/28/2008 | US20080206736 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 08/28/2008 | US20080206735 comprises a significant increase of available surface for adherent or semi-adherent growth of cell cultures, controllable and improved convection of the liquid medium and the nutritional compounds, and/or significant improvement of gas exchange and equilibrium of oxygen and CO2 |
| 08/28/2008 | US20080206734 High surface cultivation system with filler |
| 08/28/2008 | US20080206733 Method of Inducing Differentiation of Embryo-Stem Cell Into Hepatocyte and Hepatocyte Induced by the Method |
| 08/28/2008 | US20080206352 Extract for Preventing or Treating Thrombotic Diseases |
| 08/28/2008 | US20080206344 Endocytotic particles |
| 08/28/2008 | US20080206343 Contacting with sodium butyrate; for treatment of trauma, inflammation, and degenerative disorders of the liver; model mouse |
| 08/28/2008 | US20080206341 Lipid Nanoparticles as Vehicles for Nucleic Acids, Process for Their Preparation and Use |
| 08/28/2008 | US20080206287 synergistic anticarcinogenic treatment including vaccine which has a tumor necrosis factor death domains |
| 08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206264 when bound by a highly potent human neutralizing monoclonal antibody specific for a V3 conformational epitope; immunogens for inducing broadly-neutralizing antibodies against HIV-1 as well as antagonists for inhibiting the binding of HIV-1 to the relevant co-receptors |
| 08/28/2008 | US20080206262 complexing of multiple antigens or proteins in a controlled, multivariable fashion, to one single primary recombinant monoclonal antibody; activate dendritic cells and other cells; bound to one half of a Coherin/Dockerin pair |
| 08/28/2008 | US20080206254 human monoclonal antibody of the IgG isotype; preventing and treating cardiovascular disorders; specifically binds to the A2 domain of FVIII |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
| 08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206238 Angiogenesis-Inhibiting Chimeric Protein and the Use |
| 08/28/2008 | US20080206236 Polyclonal antibody product |
| 08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206232 Compositions and Methods For Modulating Pgc-1Beta to Treat Lipid-Related Diseases and Disorders |
| 08/28/2008 | US20080206231 Using herstatin as therapeutic in treatment and prevention of diabetes, cardiac disease, diabetes-associated vascular disease, atherosclerosis, hypertension, obesity, lipid metabolism obesity and neurodegenerative disorders |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206229 Modified Antibodies Recognizing Receptor Trimers or Higher Multimers |
| 08/28/2008 | US20080206220 Using NADH:flavin oxidoreductase as screening tool in identifying modulators for use in treatment of fungal infection |
| 08/28/2008 | US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 08/28/2008 | US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
| 08/28/2008 | US20080206210 gene therapy by intrathymic administration; lentiviral vectors |
| 08/28/2008 | US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord |
| 08/28/2008 | US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine |
| 08/28/2008 | US20080206206 Bone marrow-derived neuronal cells |
| 08/28/2008 | US20080206205 Using immunoaffinity, ficoll centrifugation and fluorescent cell sorting to isolate cells express ing cd34 antigen; treating cell proliferative disorders |
| 08/28/2008 | US20080206204 Using ionomycin and 6-dimethylaminopurine to induce parthenogenetic activation in non-inseminated human oocytes; treating diabetic, liver, blood, nervous system and cell prolierative disorders; regenerative medicine; tissue engineering |
| 08/28/2008 | US20080206203 Administering leukotriene antagonist such as pranlukast |
| 08/28/2008 | US20080206202 Propagating nervous system tissues from stem cell tissue in mixture comprising dimethylsulfoxide; treating muscular disorders; tissue engineering; regenerative medicine |
| 08/28/2008 | US20080206201 Oncolytic myxovirus for targeting and destroying cancer cell; antitumor agents; tissue targeted therapy |
| 08/28/2008 | US20080206200 Selected endothelial progenitor cells and methods for use |
| 08/28/2008 | US20080206199 Viral vector for target destruction of cancer cells |
| 08/28/2008 | US20080206197 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 08/28/2008 | US20080206196 Differentiation of cord blood into neural like cells, and method to treat neurological condition patients |
| 08/28/2008 | US20080206190 Glycosylated IL-7, Preparation And Uses |
| 08/28/2008 | US20080206154 Kill, inhibit growth or prevent the production of endogenously expressed toxin; treatment of sepsis |
| 08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
| 08/28/2008 | US20080206133 Patient-specific anticancer monoclonal antibodies for staging and diagnosis of a cancer, treating tumors and metastases; monoclonal antibody produced by hybridoma; conjugates with cytotoxic agents for tissue-targeted therapy |
| 08/28/2008 | US20080206132 Cancerous Disease Modifying Antibodies |
| 08/28/2008 | US20080206130 In vivo panning for ligands to radiation-induced molecules |
| 08/28/2008 | DE102007009264A1 New 9-alkyl-beta-carboline compounds are dopamine receptor stimulators useful to treat and/or prevent movement disorder, Alzheimer's disease, Parkinson's disease and Wilson's diseases, and as additives for accelerating cell growth |
| 08/28/2008 | CA2717664A1 Compositions and methods useful for site-directed recombination in plants |
| 08/28/2008 | CA2679109A1 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
| 08/28/2008 | CA2678870A1 Human pancreatic beta cell lines for diagnostic of diabetes |
| 08/28/2008 | CA2678762A1 Altering carotenoid profiles in plants |
| 08/28/2008 | CA2678755A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | CA2678493A1 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961818A2 Novel fetal genes |
| 08/27/2008 | EP1961817A1 Method for production of protein having non-natural type amino acid integrated therein |
| 08/27/2008 | EP1961816A1 Novel highly functional enzyme having modified substrate-specificity |
| 08/27/2008 | EP1961814A1 Recombinant polyvalent vaccine |
| 08/27/2008 | EP1961813A2 Human cyclin-dependent kinase (hPNQALRE) |
| 08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
| 08/27/2008 | EP1961810A1 Method for obtaining intestinal stem-precursor cell |
| 08/27/2008 | EP1961809A1 Tissue construct-forming substrate, tissue construct-forming kit, method for forming tissue construct using the same and three-dimensional tissue construct formed by the method |
| 08/27/2008 | EP1961808A2 Surface element and/or three dimensional spatial element made from cells |
| 08/27/2008 | EP1961768A1 Recombinant IL-18 Antibodies useful in Treatment of IL-18 mediated Disorders |
| 08/27/2008 | EP1961761A1 Novel peptide compound |
| 08/27/2008 | EP1961425A2 Methods and compositions for the prevention and treatment of anemia |
| 08/27/2008 | EP1961293A2 Phytate polynucleotides and methods of use |
| 08/27/2008 | EP1960777A2 Serum-free expansion of cells in culture |
| 08/27/2008 | EP1960553A2 Pulmonary stem cells, related methods and kits |
| 08/27/2008 | EP1960527A2 Methods for generating antigen-specific effector t cells |
| 08/27/2008 | EP1960523A1 Modified pore-forming protein toxins and use thereof |
| 08/27/2008 | EP1960514A1 Recombinant cell lines for the stable and high-level production of biologically active dkk1 protein |
| 08/27/2008 | EP1960513A2 Non-woven fabric for biomedical application based on poly (ester-amide)s |
| 08/27/2008 | EP1960512A2 Microaggregates including endothelial cells |
| 08/27/2008 | EP1799027A4 Certain plants with no saturate or reduced saturate levels of fatty acids in seeds, and oil derived from the seeds |
| 08/27/2008 | EP1743012A4 Methods for generating neuronal cells from human embryonic stem cells and uses thereof |
| 08/27/2008 | EP1521774B1 Truncated tau proteins |
| 08/27/2008 | EP1482807B1 Food fermentation with lactic acid bacteria |